Pew Testifies to Congress on Implementation of the Federal Compounding Law

Elizabeth Jungman, director of public health programs at The Pew Charitable Trusts, testified Jan. 30 before the House of Representatives’ Energy and Commerce Subcommittee on Health at a hearing titled “Examining Implementation of the Compounding Quality Act.”

In her testimony, Jungman conveyed Pew’s strong support for the continued robust implementation and enforcement of the Drug Quality and Security Act (DQSA), and Pew’s firm belief that weakening the DQSA would harm patient safety. She also shared some early findings from a study Pew will publish next month showing that the DQSA has been complemented by improved compounding oversight in the states.